Skip to main content

Varicella Zoster Virus

  • Chapter
  • First Online:
Acneiform Eruptions in Dermatology

Abstract

Varicella zoster virus causes two clinical syndromes. Chicken pox, or varicella, is a self-limiting disease of childhood characterized by a highly pruritic rash. Shingles, or herpes zoster, is a reactivation of the virus typically seen in adults. Heberden first distinguished these illness as separate entities in 1767 [1], and Osler emphasized the distinction in his book on clinical medicine [2]. Their relation was suggested by von Bokay in 1892 when he noted that children developed varicella after coming into contact with herpes zoster patients [3]. Weller et al. proved a common etiological agent [3–5], and Garland and Hope-Simpson were the first to propose a reactivation of latent varicella as the cause of herpes zoster [3]. In 1995, the FDA approved the first vaccine for the prevention of varicella, significantly changing the epidemiology of this disease [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gordon JE. Chickenpox: an epidemiological review. Am J Med Sci. 1962;244:362–89.

    Article  PubMed  CAS  Google Scholar 

  2. Tyring SK, Moore AY, Lupi O, editors. Mucocutaneous manifestations of viral diseases. London: Informa Healthcare; 2010.

    Google Scholar 

  3. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361–81.

    PubMed  CAS  Google Scholar 

  4. Weller TH, Witton HM. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro. J Exp Med. 1958;108:869–90.

    Article  PubMed  CAS  Google Scholar 

  5. Weller TH, Witton HM, Bell EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med. 1958;108:843–68.

    Article  PubMed  CAS  Google Scholar 

  6. Creed R, Satyaprakash A, Ravanfar P. Varicella zoster vaccines. Dermatol Ther. 2009;22:143–9.

    Article  PubMed  Google Scholar 

  7. Shah AP, Smolensky MH, Burau KD, Cech IM, Lai D. Seasonality of primarily childhood and young adult infectious diseases in the United States. Chronobiol Int. 2006;23:1065–82.

    Article  PubMed  Google Scholar 

  8. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA. 2002;287:606–11.

    Article  PubMed  Google Scholar 

  9. Roush SW, Murphy TV. Vaccine-preventable disease table working G. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155–63.

    Article  PubMed  CAS  Google Scholar 

  10. Gershon AA. Varicella-zoster virus infections. Pediatr Rev. 2008;29:5–10. quiz 1.

    Article  PubMed  Google Scholar 

  11. Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites–United States, 1995–2005. J Infect Dis. 2008;197 Suppl 2:S71–5.

    Article  PubMed  Google Scholar 

  12. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172:706–12.

    Article  PubMed  CAS  Google Scholar 

  13. Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9:21–6.

    Article  PubMed  Google Scholar 

  14. Ragozzino MW, Melton 3rd LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310–6.

    CAS  Google Scholar 

  15. Lapolla W TS. Clinical decision support in dermatology: herpes zoster. Heyman et al., Elsevier 2011.

    Google Scholar 

  16. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992;166:1153–6.

    Article  PubMed  CAS  Google Scholar 

  17. Gnann Jr JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347:340–6.

    Article  PubMed  Google Scholar 

  18. Lee MR, Ryman W. Herpes zoster following cryosurgery. Australas J Dermatol. 2005;46:42–3.

    Article  PubMed  Google Scholar 

  19. Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, Tyring SK. Family history as a risk factor for herpes zoster: a case–control study. Arch Dermatol. 2008;144:603–8.

    Article  PubMed  Google Scholar 

  20. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86:88–93.

    Article  PubMed  Google Scholar 

  21. Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–76.

    Article  PubMed  Google Scholar 

  22. Taylor SL, Moffat JF. Replication of varicella-zoster virus in human skin organ culture. J Virol. 2005;79:11501–6.

    Article  PubMed  CAS  Google Scholar 

  23. Eshleman E, Shahzad A, Cohrs RJ. Varicella zoster virus latency. Future Virol. 2011;6:341–55.

    Article  PubMed  Google Scholar 

  24. Abendroth A, Arvin A. Varicella-zoster virus immune evasion. Immunol Rev. 1999;168: 143–56.

    Article  PubMed  CAS  Google Scholar 

  25. Kost RG, Straus SE. Postherpetic neuralgia–pathogenesis, treatment, and prevention. N Engl J Med. 1996;335:32–42.

    Article  PubMed  CAS  Google Scholar 

  26. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol. 1999;41:1–14. quiz 5–6.

    Article  PubMed  CAS  Google Scholar 

  27. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. 1999;130:922–32.

    Article  PubMed  CAS  Google Scholar 

  28. Chen TM, George S, Woodruff CA, Hsu S. Clinical manifestations of varicella-zoster virus infection. Dermatol Clin. 2002;20:267–82.

    Article  PubMed  Google Scholar 

  29. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970–1994. J Infect Dis. 2000;182:383–90.

    Article  PubMed  CAS  Google Scholar 

  30. Weber DM, Pellecchia JA. Varicella pneumonia: study of prevalence in adult men. JAMA. 1965;192:572–3.

    Article  PubMed  CAS  Google Scholar 

  31. Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis. 2011;203:316–23.

    Article  PubMed  Google Scholar 

  32. Gnann Jr JW. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186 Suppl 1:S91–8.

    Article  PubMed  Google Scholar 

  33. Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med. 1994;330:901–5.

    Article  PubMed  CAS  Google Scholar 

  34. Burgoon Jr CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. J Am Med Assoc. 1957;164:265–9.

    Article  PubMed  Google Scholar 

  35. Vander Straten M, Carrasco D, Lee P, Tyring SK. Reduction of postherpetic neuralgia in herpes zoster. J Cutan Med Surg. 2001;5:409–16.

    Article  PubMed  CAS  Google Scholar 

  36. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545–51.

    Article  PubMed  Google Scholar 

  37. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115:S3–12.

    Article  PubMed  Google Scholar 

  38. Liesegang TJ. The varicella-zoster virus: systemic and ocular features. J Am Acad Dermatol. 1984;11:165–91.

    Article  PubMed  CAS  Google Scholar 

  39. Lai J, Fay KE, Bocchini JA. Update on childhood and adolescent immunizations: selected review of US recommendations and literature: part 2. Curr Opin Pediatr. 2011;23:470–81.

    Article  PubMed  Google Scholar 

  40. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007;356:1338–43.

    Article  PubMed  CAS  Google Scholar 

  41. Whitley RJ, Volpi A, McKendrick M, Wijck A, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010;48 Suppl 1:S20–8.

    Article  PubMed  CAS  Google Scholar 

  42. Andrei G, Snoeck R. Emerging drugs for varicella-zoster virus infections. Expert Opin Emerg Drugs. 2011;16(3):507–35.

    Article  PubMed  Google Scholar 

  43. Lapolla W, Digiorgio C, Haitz K, Magel G, Mendoza N, Grady J, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol. 2011;147(8):901–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel Gordon M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gordon, R., Tyring, S., Lapolla, W., Mays, R. (2014). Varicella Zoster Virus. In: Zeichner, J. (eds) Acneiform Eruptions in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8344-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8344-1_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8343-4

  • Online ISBN: 978-1-4614-8344-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics